Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Mouse Lifespan Increased 20% by Single Gene Alteration

By BiotechDaily International staff writers
Posted on 19 Sep 2013
Image: By lowering the expression of a single gene, called mTOR, scientists have extended the average lifespan of a group of mice by about 20% (Photo courtesy of the US National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute (NHLBI)).
Image: By lowering the expression of a single gene, called mTOR, scientists have extended the average lifespan of a group of mice by about 20% (Photo courtesy of the US National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute (NHLBI)).
By lowering the expression of a single gene, US researchers have extended the average lifespan of a group of lab mice by about 20%—the equivalent of raising the average human lifespan by 16 years, from 79 to 95.

The researchers targeted a gene called mTOR, which is involved in metabolism and energy balance, and may be connected with the increased lifespan associated with caloric restriction.

A detailed study of these mice, published in the August 29, 2013, of the journal Cell Reports, revealed that gene-influenced lifespan extension did not affect every organ and tissue in the same manner. For example, the mice retained better memory and balance as they aged, but their bones deteriorated more rapidly than normal.

“While the high extension in lifespan is noteworthy, this study reinforces an important facet of aging; it is not uniform,” said lead researcher Toren Finkel, MD, PhD, at the US National Institutes of Health’s (NIH) National Heart, Lung, and Blood Institute (NHLBI; Bethesda, MD, USA). “Rather, similar to circadian rhythms, an animal might have several organ-specific aging clocks that generally work together to govern the aging of the whole organism.”

Dr. Finkel, who heads the NHLBI’s Laboratory of Molecular Biology in the Division of Intramural Research, noted that these findings may help guide therapies for aging-related diseases that target specific organs, such as Alzheimer’s disease. However, additional research in these mice as well as human cells are required to figure out precisely how aging in these diverse tissues is linked at the molecular level.

The researchers modified mice that make approximately 25% of the normal amount of the mTOR protein, or about the minimum needed for survival. The engineered mTOR mice were a little smaller than average, but they otherwise appeared normal. The median lifespan for the mTOR mice was 28.0 months for males and 31.5 months for females, compared to 22.9 months and 26.5 months for normal males and females, respectively. The mTOR mice also had a longer maximal lifespan; seven of the eight longest-lived mice in this study were mTOR mice. This lifespan increase is one of the largest observed in mice up to now.

Whereas the genetically modified mTOR mice aged better overall, they revealed only selective improvement in specific organs. They typically outperformed normal mice of same age in maze and balance tests, indicating better retention of memory and coordination. Older mTOR mice also retained more muscle strength and posture. However, mTOR mice had more loss of bone volume as they aged, and they were more prone to infections at old age, suggesting a reduction of immune function.

Related Links:
US National Heart, Lung, and Blood Institute


comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more

Business

view channel

Interest in Commercial Applications for Proteomics Continues to Grow

Increasing interest in the field of proteomics has led to a series of agreements between private proteomic companies and academic institutions as well as deals between pharmaceutical companies and novel proteomics innovator biotech companies. Proteomics is the study of the structure and function of proteins.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.